Vascular permeability can reflect tumorigenesis and metastasis. Previous dynamic contrast-enhanced magnetic resonance imaging based pharmacokinetic parameters estimation needs to manually select arterial input function (AIF) or reference regions (RR), and the results depend sensitively on the AIF selection. Our goal is to develop a more robust estimation approach without previously provided AIF or RR regions, for examining bone metastases from prostate cancer.